The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.
Open accessAbstract
Catecholamine secretory vesicle core proteins (chromogranins) contain an activity that inhibits catecholamine release, but the identity of the responsible peptide has been elusive. Size-fractionated chromogranins antagonized nicotinic cholinergic-stimulated catecholamine secretion; the inhibitor was enriched in processed chromogranin fragments, and was liberated from purified chromogranin A. Of 15 synthetic peptides spanning approximately 80% of chromogranin A, one (bovine chromogranin A344-364 [RSMRLSFRARGYGFRGPGLQL], or catestatin) was a potent, dose-dependent (IC50 approximately 200 nM), reversible secretory inhibitor on pheochromocytoma and adrenal chromaffin cells, as well as noradrenergic neurites. An antibody directed against this peptide blocked the inhibitory effect of chromogranin A proteolytic fragments on nicotinic-stimulated catecholamine secretion. This region of chromogranin A is extensively processed within chromaffin vesicles in vivo. The inhibitory effect was specific for nicotinic cholinergic stimulation of catecholamine release, and was shared by this chromogranin A region from several species. Nicotinic cationic (Na+, Ca2+) signal transduction was specifically disrupted by catestatin. Even high-dose nicotine failed to overcome the inhibition, suggesting noncompetitive nicotinic antagonism. This small domain within chromogranin A may contribute to a novel, autocrine, homeostatic (negative-feedback) mechanism controlling catecholamine release from chromaffin cells and neurons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,647
Greene, L. A., & Tischler, A. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2424 · Cited by 5,553
Molloy, S. S., Bresnahan, P. A., Leppla, S. H., Klimpel, K. R., & Thomas, G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42016-9 · Cited by 689
Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion
Tatemoto, K., Efendić, S., Mutt, V., Makk, G., Feistner, G. J., & Barchas, J. D. (1986) · Nature · doi:10.1038/324476a0 · Cited by 681
The chromogranins A and B: The first 25 years and future perspectives
Winkler, H., & Fischer-Colbrie, R. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90222-n · Cited by 655
BLASCHKO, H., COMLINE, R. S., SCHNEIDER, F. H., SILVER, M., & SMITH, A. D. (1967) · Nature · doi:10.1038/215058a0 · Cited by 520
Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms
O'Connor, D. T., & Deftos, L. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605013141803 · Cited by 477
Self-citationThe molecular function of adrenal chromaffin granules: Established facts and unresolved topics
Winkler, H., Apps, D. K., & Fischer-Colbrie, R. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90154-5 · Cited by 354
The primary structure of human chromogranin A and pancreastatin.
Konecki, D. S., Benedum, U. M., Gerdes, H. H., & Huttner, W. B. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45486-5 · Cited by 288
Milligan, G. (1988) · Biochemical Journal · doi:10.1042/bj2550001 · Cited by 273
Benedum, U. M., Baeuerle, P. A., Konecki, D. S., Frank, R., Powell, J., Mallet, J., & Huttner, W. B. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04388.x · Cited by 250
CHATTOPADHYAY, N., MITHAL, A., & BROWN, E. M. (1996) · Endocrine Reviews · doi:10.1210/edrv-17-4-289 · Cited by 240
SECRETION FROM THE ADRENAL MEDULLA: BIOCHEMICAL EVIDENCE FOR EXOCYTOSIS
SCHNEIDER, F. H., SMITH, A. D., & WINKLER, H. (1967) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1967.tb01980.x · Cited by 223
O'Connor, D. T., & Frigon, R. P. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43286-8 · Cited by 213
Self-citationIACANGELO, A. L., FISCHER-COLBRIE, R., KOLLER, K. J., BROWNSTEIN, M. J., & EIDEN, L. E. (1988) · Endocrinology · doi:10.1210/endo-122-5-2339 · Cited by 196
Aardal, S., & Helle, K. B. (1992) · Regulatory Peptides · doi:10.1016/0167-0115(92)90509-s · Cited by 191
Intracellular and extracellular processing of chromogranin A: Determination of cleavage sites
METZ‐BOUTIGUE, M., GARCIA‐SABLONE, P., HOGUE‐ANGELETTI, R., & AUNIS, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18240.x · Cited by 181
The expression of nicotinic acetylcholine receptors by PC12 cells treated with NGF
Rogers, S., Mandelzys, A., Deneris, E., Cooper, E., & Heinemann, S. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-12-04611.1992 · Cited by 162
Molecular cloning and primary structure of human chromogranin A (secretory protein I) cDNA.
Helman, L. J., AHN, T. G., Levine, M. A., Allison, A., Cohen, P. S., Cooper, M. J., Cohn, D. V., & Israel, M. A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37995-x · Cited by 148
Pandol, S. J., Schoeffield, M. S., Fimmel, C. J., & Muallem, S. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45478-6 · Cited by 142
Galindo, E., Rill, A., Bader, M. F., & Aunis, D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1426 · Cited by 138
Fasciotto, B. H., Trauss, C., Greeley, G. H., & Cohn, D. V. (1993) · Endocrinology · doi:10.1210/endo.133.2.8344192 · Cited by 124
Eskeland, N. L., Zhou, A., Dinh, T., Wu, H., Parmer, R. J., Mains, R. E., & O’Connor, D. T. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118760 · Cited by 110
Self-citationStructure and function of the chromogranin A gene. Clues to evolution and tissue-specific expression
Wu, H. J., Rozansky, D. J., Parmer, R. J., Gill, B. M., & O’Connor, D. T. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98814-9 · Cited by 105
Self-citationTaupenot, L., Ciesielski-Treska, J., Ulrich, G., Chasserot‐Golaz, S., Aunis, D., & Bader, M. F. (1996) · Neuroscience · doi:10.1016/0306-4522(96)83172-1 · Cited by 94
Self-citationHoflehner, J., Eder, U., Laslop, A., Seidah, N. G., Fischer‐Colbrie, R., & Winkler, H. J. S. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00127-u · Cited by 80
Posttranslational processing of proenkephalins and chromogranins/secretogranins
Dillen, L., Miserez, B., Claeys, M., Aunis, D., & Potter, W. D. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90016-x · Cited by 76
Arden, S. D., Rutherford, N. G., Guest, P. C., Curry, W. J., BAILYES, E. M., Johnston, C. F., & Hutton, J. C. (1994) · Biochemical Journal · doi:10.1042/bj2980521 · Cited by 68
Curry, W. J., Shaw, C., Johnston, C. F., et al. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80266-j · Cited by 64
Noncholinergic control of adrenal catecholamine secretion.
Livett, B. G., & Marley, P. D. (1993) · PubMed · Cited by 56
Chromostatin receptors control calcium channel activity in adrenal chromaffin cells.
Galindo, E., Mendez, M., Calvo, S., Gonzalez-Garcia, C., Ceña, V., Hubert, P., Bader, M. F., & Aunis, D. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48509-2 · Cited by 40
Vesicular Monoamine Transport Inhibitors
Mahata, M., Mahata, S. K., Parmer, R. J., & O’Connor, D. T. (1996) · Hypertension · doi:10.1161/01.hyp.28.3.414 · Cited by 39
Self-citationDrees, B. M., & Hamilton, J. W. (1994) · Endocrinology · doi:10.1210/endo.134.5.8156905 · Cited by 26
Hagiwara, D., Miyake, H., Morimoto, H., et al. (1992) · Journal of Medicinal Chemistry · doi:10.1021/jm00089a011 · Cited by 22
Cited by
The Chromogranin–Secretogranin Family
Taupenot, L., Harper, K. L., & O'Connor, D. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021405 · Cited by 819
Self-citationThe Extended Granin Family: Structure, Function, and Biomedical Implications
Bartolomucci, A., Possenti, R., Mahata, S. K., Fischer-Colbrie, R., Loh, Y. P., & Salton, S. R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0027 · Cited by 348
Self-citationHypertension from targeted ablation of chromogranin A can be rescued by the human ortholog
Mahapatra, N. R., O’Connor, D. T., Vaingankar, S. M., Hikim, A. P. S., Mahata, M., Ray, S., Staite, E., Wu, H., Gu, Y., Dalton, N., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24354 · Cited by 309
Self-citationAntimicrobial peptides: natural effectors of the innate immune system
Radek, K., & Gallo, R. (2007) · Seminars in Immunopathology · doi:10.1007/s00281-007-0064-5 · Cited by 275
Borovac, J. A., D'Amario, D., Bozic, J., & Glavas, D. (2020) · World Journal of Cardiology · doi:10.4330/wjc.v12.i8.373 · Cited by 195
Metadata
- Authors
- Mahata, S. K., O'Connor, D. T., Mahata, M., Yoo, S. H., Taupenot, L., Wu, H., Gill, B. M., & Parmer, R. J.
- Venue
- Journal of Clinical Investigation
- Published
- 1997-09-15
- Volume
- 100
- Issue
- 6
- Pages
- 1623-1633
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2003049002
- Cited by
- 394
- References
- 35
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.